Xconomy National

by in

Entry	Author	Date	Location
Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News	Erin Kutz	08/17/11	Boston
Alkermes Sees Chance to Reinvent Vivitrol For Fighting Drug Addiction, Not Just Alcoholism	Luke Timmerman	02/18/11	Boston
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box	Ryan McBride	11/15/10	Boston
Omeros Addiction Program Wins NIH Grant	Luke Timmerman	10/14/10	Seattle
Alkermes Files Drug App With FDA	Luke Timmerman	04/13/10	Boston
Alkermes to Seek FDA Approval of Anti-Addiction Drug	Ryan McBride	11/16/09	Boston
Alkermes’ Ambitious Builder, Richard Pops, Grabs Reins to Re-Ignite Growth Phase	Luke Timmerman	09/28/09	Boston
Alkermes, Swinging For the Fence, Touts New Anti-Addiction Drug	Luke Timmerman	04/07/09	Boston
Page 1 of 1